MedPath
NMPA Approval

Odevixibat Capsules

国药准字HJ20240148

December 1, 2024

Drug Information

奥德昔巴特胶囊

蓓尔唯

胶囊剂

400µg(按C₃₇H₄₈N₄O₈S₂计)

化学药品

December 1, 2024

November 30, 2029

Company Information

Applicant Company

IPSEN PHARMA

65 quai Georges Gorse, 92100 Boulogne-Billancourt, France

Manufacturing Company

PATHEON FRANCE

40, Boulevard de Champaret Bourgoin-Jallieu, 38300 France

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.